Table 2.
Demographic Characteristics
| Characteristic | Fluconazole (n = 299) | Placebo (n = 279) | P Value |
|---|---|---|---|
| Gestational age, wka | 25 (24, 27) | 26 (25, 27) | .10 |
| Birth weight, ga | 680 (600, 745) | 680 (595, 760) | .91 |
| <750 | 226 (76) | 202 (72) | |
| 750–1000 | 45 (15) | 53 (19) | |
| >1000 | 28 (9) | 24 (9) | |
| Race | .98 | ||
| White | 126 (42) | 120 (43) | |
| African-American | 158 (53) | 145 (52) | |
| Other | 15 (5) | 14 (5) | |
| Male | 132 (44) | 126 (45) | .81 |
| Inborn | 254 (85) | 240 (86) | .72 |
| Cesarean delivery | 191 (64) | 196 (70) | .10 |
| Intubated at randomization | 200/239 (84) | 182/223 (82) | .56 |
| Prolonged rupture of membranes | 61/294 (21) | 63/274 (23) | .52 |
| Antenatal steroids | 227 (76) | 227 (81) | .11 |
| Prenatal antibiotics | 140/246 (57) | 127/229 (55) | .75 |
Data are presented as No. (%) unless otherwise indicated.
a Median (25th, 75th percentile).